Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
1. Aptevo Therapeutics Inc. shares fell 11.9% to $4.52 in pre-market trading. 2. The company experienced an 82% increase on Wednesday post-clinical data announcement. 3. Market overall was lower, with Dow futures down 0.2% this morning. 4. Other biotech stocks also showed declines during pre-market trading. 5. Smith & Wesson's disappointing earnings report affected overall market sentiment.